U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

See more countries

Results: 1 to 20 of 84

Tests names and labsConditionsGenes, analytes, and microbesMethods

Bone marrow culture for cancer

Institute of Human Genetics Foundation for Research in Genetics and Endocrinology
India
424
  • K Karyotyping

BCR/ABL translocation study

Institute of Human Genetics Foundation for Research in Genetics and Endocrinology
India
12
  • F Fluorescence in situ hybridization (FISH)

Solid Tumor Panel

Centogene AG - the Rare Disease Company
Germany
218135
  • C Sequence analysis of the entire coding region

ABL1 - NGS including CNV analysis

Centogene AG - the Rare Disease Company
Germany
21
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoDysmorph Panel

Centogene AG - the Rare Disease Company
Germany
740728
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Connective Tissue Disorders Panel

Invitae
United States
19592
  • D Deletion/duplication analysis

BCR-ABL1 Quantitation

Sentara Healthcare Laboratory Services
United States
12
  • R RNA analysis

Hematological Malignancy Fusion Panel

Laboratory for Molecular Pediatric Pathology Boston Children's Hospital
United States
871
  • R RNA analysis

BCR/ABL IS Quant CML and JAK2 V617F Quant and JAK2 Exon 12-15

PathGroup
United States
73
  • T Targeted variant analysis

BCR/ABL IS Quant CML and JAK2 V617F Quant

PathGroup
United States
73
  • T Targeted variant analysis

BCR CML IS_expanded JAK2 +V617F quant_CALR_MPL

PathGroup
United States
115
  • T Targeted variant analysis

BCR CML IS_JAK2_CALR_MPL

PathGroup
United States
115
  • T Targeted variant analysis

BCR/ABL CML IS, CALR and JAK2 exon 12-15 (V617F Quant)

PathGroup
United States
104
  • T Targeted variant analysis

Comprehensive HemeComplete Profile + CALR PCR + FLT3 PCR + BCR/ABL1 IS

PathGroup
United States
17160
  • T Targeted variant analysis

BCR/ABL IS Quant CML+CALR+Expanded JAK2

PathGroup
United States
104
  • T Targeted variant analysis

BCR/ABL, CALR, JAK2, MPL

PathGroup
United States
115
  • T Targeted variant analysis

BCR/ABL Quant Non-CML and JAK2 V617F Mutation Detect and Quant

PathGroup
United States
73
  • T Targeted variant analysis

BCR/ABL, CALR, expanded JAK2, MPL

PathGroup
United States
115
  • T Targeted variant analysis

Comprehensive HemeComplete Profile + CALR PCR + FLT3 PCR + BCR/ABL1

PathGroup
United States
17160
  • T Targeted variant analysis

BCR/ABL Quant Non-CML, CALR and JAK2 exon 12-15 (V617F Quant)

PathGroup
United States
104
  • T Targeted variant analysis

Results: 1 to 20 of 84

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.